PropThink: Earnings Are Hardly the Focus of Pharmacyclics’ Fiscal 1Q13 Financial Report

[ACN Newswire] – By Jake KingIn one of Monday’s notable volume abnormalities, shares of Pharmacyclics (NASDAQ:PCYC) have exchanged hands at more than five times average volume, and PCYC is down 11% following the company’s … more

View todays social media effects on PCYC

View the latest stocks trending across Twitter. Click to view dashboard